{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:24:18Z","timestamp":1787091858018,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"DOI":"10.1007\/s11764-026-02102-5","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T21:30:01Z","timestamp":1787088601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subsequent malignant neoplasm among cancer survivors in the United States"],"prefix":"10.1007","author":[{"given":"Emily S.","family":"Tonorezos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa P.","family":"Devasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Gallicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Doose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo J.","family":"Santiago-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"11","key":"2102_CR1","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/jnci\/djae135","volume":"116","author":"E Tonorezos","year":"2024","unstructured":"Tonorezos E, Devasia T, Mariotto AB, Mollica MA, Gallicchio L, Green P, et al. Prevalence of cancer survivors in the United States. J Natl Cancer Inst. 2024;116(11):1784\u201390.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2102_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamaoncol.2025.0236","volume":"11","author":"JM Yeh","year":"2025","unstructured":"Yeh JM, Ward ZJ, Stratton KL, McMahon MV, Taylor CS, Armstrong GT, et al. Accelerated aging in survivors of childhood cancer-early onset and excess risk of chronic conditions. JAMA Oncol. 2025;11(5):535\u201343.","journal-title":"JAMA Oncol"},{"issue":"15","key":"2102_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70057","volume":"13","author":"HS Ng","year":"2024","unstructured":"Ng HS, Meng R, Marin TS, Damarell RA, Buckley E, Selvanayagam JB, et al. Cardiovascular mortality in people with cancer compared to the general population: a systematic review and meta-analysis. Cancer Med. 2024;13(15).","journal-title":"Cancer Med"},{"issue":"1","key":"2102_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12967-025-06379-5","volume":"23","author":"Y Wang","year":"2025","unstructured":"Wang Y, Jiang Y, Bai Y, Xu H. Do cancer survivors have an increased risk of developing subsequent cancer? A population-based study. J Transl Med. 2025;23(1):355.","journal-title":"J Transl Med"},{"issue":"6","key":"2102_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","volume":"4","author":"CC Murphy","year":"2018","unstructured":"Murphy CC, Gerber DE, Pruitt SL. Prevalence of prior cancer among persons newly diagnosed with cancer: an initial report from the Surveillance, Epidemiology, and End Results Program. JAMA Oncol. 2018;4(6):832\u20136.","journal-title":"JAMA Oncol"},{"issue":"1 Pt 2","key":"2102_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jfma.2021.05.012","volume":"121","author":"WL Ho","year":"2022","unstructured":"Ho WL, Hung GY, Yen HJ, Yang YL, Chang HH, Lu MY, et al. Characteristics and outcomes of second cancers in patients with childhood cancer: a report from the Taiwan Pediatric Oncology Group. J Formos Med Assoc. 2022;121(1 Pt 2):350\u20139.","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"2102_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10147-019-01427-9","volume":"24","author":"X Guo","year":"2019","unstructured":"Guo X, Liu M, Hou H, Liu S, Zhang X, Zhang Y, et al. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer. Int J Clin Oncol. 2019;24(8):957\u201365.","journal-title":"Int J Clin Oncol"},{"issue":"15","key":"2102_CR8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/bloodadvances.2018020966","volume":"2","author":"Y Inamoto","year":"2018","unstructured":"Inamoto Y, Matsuda T, Tabuchi K, Kurosawa S, Nakasone H, Nishimori H, et al. Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation. Blood Adv. 2018;2(15):1901\u201313.","journal-title":"Blood Adv"},{"issue":"1","key":"2102_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cam4.1922","volume":"8","author":"LS Rigter","year":"2019","unstructured":"Rigter LS, Schaapveld M, Janus CPM, Krol ADG, van der Maazen RWM, Roesink J, et al. Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer. Cancer Med. 2019;8(1):190\u20139.","journal-title":"Cancer Med"},{"issue":"6","key":"2102_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.5536","volume":"2","author":"C Chao","year":"2019","unstructured":"Chao C, Bhatia S, Xu L, Cannavale KL, Wong FL, Huang PS, et al. Incidence, risk factors, and mortality associated with second malignant neoplasms among survivors of adolescent and young adult cancer. JAMA Netw Open. 2019;2(6).","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2102_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaccao.2021.12.003","volume":"4","author":"AH Blaes","year":"2022","unstructured":"Blaes AH, Konety S, Hui J, Dusenbery K, Yuan J, Dent S, et al. How to treat breast cancer after childhood cancer: management of oncologic and cardiovascular concerns. JACC CardioOncol. 2022;4(1):126\u20139.","journal-title":"JACC CardioOncol"},{"issue":"14","key":"2102_CR12","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","volume":"27","author":"GT Armstrong","year":"2009","unstructured":"Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2328\u201338.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2102_CR13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/jnci\/djab054","volume":"113","author":"Y Park","year":"2021","unstructured":"Park Y, Colditz GA. Obesity elevates cancer survivors\u2019 risk of second cancer: identifying modifiable risk factors for second cancer. J Natl Cancer Inst. 2021;113(9):1113\u20134.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2102_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","volume":"12","author":"A Berrington de Gonzalez","year":"2011","unstructured":"Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol. 2011;12(4):353\u201360.","journal-title":"Lancet Oncol"},{"key":"2102_CR15","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.e57","author":"LM Morton","year":"2014","unstructured":"Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT. The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. Am Soc Clin Oncol Educ Book. 2014. https:\/\/doi.org\/10.14694\/EdBook_AM.2014.34.e57.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6","key":"2102_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1470-2045(25)00157-3","volume":"26","author":"A Neupane","year":"2025","unstructured":"Neupane A, Liu Q, Taneja S, French J, Ehrhardt MJ, Brinkman TM, et al. Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study. Lancet Oncol. 2025;26(6):806\u201316.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2102_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1158\/1055-9965.EPI-06-0782","volume":"16","author":"AB Mariotto","year":"2007","unstructured":"Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007;16(3):566\u201371.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2102_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/jnci\/djac091","volume":"114","author":"H Sung","year":"2022","unstructured":"Sung H, Siegel RL, Hyun N, Miller KD, Yabroff KR, Jemal A. Subsequent primary cancer risk among 5-year survivors of adolescent and young adult cancers. J Natl Cancer Inst. 2022;114(8):1095\u2013108.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"2102_CR19","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/cncr.30164","volume":"122","author":"N Donin","year":"2016","unstructured":"Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016;122(19):3075\u201386.","journal-title":"Cancer"},{"issue":"14","key":"2102_CR20","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1200\/JCO.2008.21.1920","volume":"27","author":"AT Meadows","year":"2009","unstructured":"Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2356\u201362.","journal-title":"J Clin Oncol"},{"issue":"14","key":"2102_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jnci\/djq238","volume":"102","author":"DL Friedman","year":"2010","unstructured":"Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102(14):1083\u201395.","journal-title":"J Natl Cancer Inst"},{"issue":"26","key":"2102_CR22","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","volume":"373","author":"M Schaapveld","year":"2015","unstructured":"Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, et al. Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma. N Engl J Med. 2015;373(26):2499\u2013511.","journal-title":"N Engl J Med"},{"issue":"8","key":"2102_CR23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/cncr.31807","volume":"125","author":"AS Holmqvist","year":"2019","unstructured":"Holmqvist AS, Chen Y, Berano Teh J, Sun C, Birch JM, van den Bos C, et al. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-identification of high-risk populations to guide surveillance: a report from the Late Effects Study Group. Cancer. 2019;125(8):1373\u201383.","journal-title":"Cancer"},{"issue":"11","key":"2102_CR24","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.bjc.6602226","volume":"91","author":"HC Jenkinson","year":"2004","unstructured":"Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer. 2004;91(11):1905\u201310.","journal-title":"Br J Cancer"},{"issue":"3","key":"2102_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","volume":"146","author":"PT Bradford","year":"2010","unstructured":"Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol. 2010;146(3):265\u201372.","journal-title":"Arch Dermatol"},{"issue":"12","key":"2102_CR26","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1200\/JCO.2000.18.12.2435","volume":"18","author":"C Metayer","year":"2000","unstructured":"Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, et al. Second cancers among long-term survivors of Hodgkin\u2019s disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18(12):2435\u201343.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2102_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ygyno.2020.06.492","volume":"158","author":"E Adjei Boakye","year":"2020","unstructured":"Adjei Boakye E, Grubb L, Peterson CE, Osazuwa-Peters N, Grabosch S, Ladage HD, et al. Risk of second primary cancers among survivors of gynecological cancers. Gynecol Oncol. 2020;158(3):719\u201326.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2102_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cam4.1437","volume":"7","author":"X He","year":"2018","unstructured":"He X, Wu W, Ding Y, Li Y, Si J, Sun L. Excessive risk of second primary cancers in young-onset colorectal cancer survivors. Cancer Med. 2018;7(4):1201\u201310.","journal-title":"Cancer Med"},{"issue":"24","key":"2102_CR29","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2020.23130","volume":"324","author":"H Sung","year":"2020","unstructured":"Sung H, Hyun N, Leach CR, Yabroff KR, Jemal A. Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA. 2020;324(24):2521\u201335.","journal-title":"JAMA"},{"key":"2102_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejca.2019.05.013","volume":"117","author":"RS Allodji","year":"1940","unstructured":"Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, et al. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: a cohort study within PanCareSurFup. Eur J Cancer. 1940;117:71\u201383.","journal-title":"Eur J Cancer"},{"issue":"20","key":"2102_CR31","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1200\/JCO.2016.71.6902","volume":"35","author":"JC Teepen","year":"2017","unstructured":"Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den BE, van den Heuvel-Eibrink MM, van der Pal HJ, et al. Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: role of chemotherapy. J Clin Oncol. 2017;35(20):2288\u201398.","journal-title":"J Clin Oncol"},{"issue":"35","key":"2102_CR32","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1200\/JCO.20.00562","volume":"38","author":"RL Mulder","year":"2020","unstructured":"Mulder RL, Hudson MM, Bhatia S, Landier W, Levitt G, Constine LS, et al. Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the International Guideline Harmonization Group. J Clin Oncol. 2020;38(35):4194\u2013207.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2102_CR33","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/jamaoncol.2024.6812","volume":"11","author":"A DeVine","year":"2025","unstructured":"DeVine A, Landier W, Hudson MM, Constine LS, Bhatia S, Armenian SH, et al. The Children\u2019s Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers: a review. JAMA Oncol. 2025;11(5):544\u201353.","journal-title":"JAMA Oncol"},{"issue":"27","key":"2102_CR34","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1200\/JCO.20.02244","volume":"39","author":"CS Moskowitz","year":"2021","unstructured":"Moskowitz CS, Ronckers CM, Chou JF, Smith SA, Friedman DN, Barnea D, et al. Development and validation of a breast cancer risk prediction model for childhood cancer survivors treated with chest radiation: a report from the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER cohorts. J Clin Oncol. 2021;39(27):3012\u201321.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2102_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaccao.2021.12.003","volume":"4","author":"AH Blaes","year":"2022","unstructured":"Blaes AH, Konety S, Hui J, Dusenbery K, Yuan J, Dent S, et al. How to treat breast cancer after childhood cancer: management of oncologic and cardiovascular concerns. JACC CardioOncol. 2022;4(1):126\u20139.","journal-title":"JACC CardioOncol"},{"issue":"24","key":"2102_CR36","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1200\/JCO.19.00547","volume":"37","author":"KC Oeffinger","year":"2019","unstructured":"Oeffinger KC, Ford JS, Moskowitz CS, Chou JF, Henderson TO, Hudson MM, et al. Promoting breast cancer surveillance: the EMPOWER study, a randomized clinical trial in the Childhood Cancer Survivor Study. J Clin Oncol. 2019;37(24):2131\u201340.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2102_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11764-021-01060-4","volume":"16","author":"EM Mobley","year":"2022","unstructured":"Mobley EM, Moke DJ, Milam J, Ochoa CY, Stal J, Osazuwa N, et al. Interventions to address disparities and barriers to pediatric cancer survivorship care: a scoping review. J Cancer Surviv. 2022;16(3):667\u201376.","journal-title":"J Cancer Surviv"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02102-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-026-02102-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02102-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T21:30:03Z","timestamp":1787088603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-026-02102-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":37,"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1007\/s11764-026-02102-5","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was performed as part of the authors\u2019 duties as employees of the United States Federal Government. Drs. Emily Tonorezos and Michelle A. Mollica were formerly with the National Cancer Institute; they are now employed by St. Jude Children\u2019s Research Hospital and the Medical University of South Carolina, respectively. The opinions expressed by the authors are their own. This material should not be interpreted as representing the official viewpoint of the US Department of Health and Human Services, the National Institutes of Health, or the National Cancer Institute.","order":2,"name":"Ethics","label":"Notes and disclaimers","group":{"name":"EthicsHeading","label":"Declarations"}}]}}